Aclaris Therapeutics to Announce First Quarter 2024 Financial Results on May 7, 2024 and to Provide Corporate Update

Core Viewpoint - Aclaris Therapeutics, Inc. is set to report its financial results for Q1 2024 on May 7, 2024, after U.S. market close, followed by a conference call for a corporate update [1]. Group 1: Company Overview - Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases [2]. - The company has a multi-stage portfolio of drug candidates supported by a robust R&D engine that explores protein kinase regulation [2].